Pfizer Inc. (NYSE: PFE) Share Price and News

$26.59 $0.03 (0.1%) Saturday, 2 March 2024 at 8:00:00 am Australian Eastern Daylight Time

Pfizer Inc. Chart and Price Data

About Pfizer

Last updated 02-03-2024, 08:00:00am AEDT
Current Price $26.59
Change $0.03 (0.1%)
Close Price $26.59
Open Price $26.83
Bid $26.58
Ask $26.59
Day Range $26.51 - $26.90
Year Range $25.76 - $42.22
Volume 46,392,099
Average Volume 46,806,745
Market Cap $150,147,880,200.00
Earnings Per Share $0.36
  • Pfizer Inc. (NYSE: PFE)
    Latest News

    coronavirus vaccine represented by gloved hand drawing down from syringe
    International Stock News

    Johnson & Johnson coronavirus vaccine wins FDA authorisation

    The big pharmaceutical company's jab has some important advantages.

    Read more »

    covid vaccine shares represented by numbers 2021 with the one displayed as syringe
    Coronavirus News

    Pfizer COVID-19 vaccine given green light for use in Australia

    The TGA has approved the Pfizer COVID-19 vaccine for use in Australia. We take a look at some of the…

    Read more »

    Share Market News

    CV Check (ASX:CV1) share price flat on results update

    The CV Check Ltd (ASX: CV1) share price remains unchanged today following the release of its Q2 FY21 scorecard.

    Read more »

    Hand with blue medical gloves holds vials of coronavirus vaccines
    International Stock News

    Moderna's stock has surged 488% in 2020: Is it a buy for 2021?

    This smaller biotech company attracted a lot of attention in 2020, but is it still worth an investment?

    Read more »

    asx share price boosted by us investment represented by hand waving US flag across winning athlete
    Share Market News

    Here are the US shares ASX investors are buying

    AirBnB Inc (NASDAQ: ABNB) and Tesla Inc (NASDAQ: TSLA) were amongst the US shares that ASX investors were buying last…

    Read more »

    Vaccine vials sitting on top of a pile of US cash
    International Stock News

    The most popular coronavirus stock may lose half its value by 2023

    This as-of-now unstoppable COVID-19 stock might be one of the worst investments going forward.

    Read more »

    vials of medication labelled with COVID-19 vaccine stickers
    Share Market News

    CSL (ASX:CSL) share price on watch after hints of 'far more robust' vaccine

    Australian global biotech giant CSL Limited didn't win the sprint for a coronavirus vaccine. But it may lead the marathon.

    Read more »

    woman waering face mask holding vial of covid-19 vaccine
    International Stock News

    Why Pfizer and BioNTech stocks popped Wednesday

    The healthcare leaders became the first to receive emergency authorization for their coronavirus vaccine.

    Read more »

    travel asx share price represented by suitcase wearing covid mask
    Share Gainers

    Which ASX travel shares performed the best in November? 

    On the back of vaccine hopes and reopening borders, which ASX travel shares performed the best in November? We take…

    Read more »

    doctor holding covid-19 vaccine bottle
    International Stock News

    3 key advantages Moderna holds over Pfizer and AstraZeneca

    They could add up to make Moderna a much bigger winner for investors than either of the two big pharma…

    Read more »

    Doctor holding small world globe in one hand and a Covid vaccine needle in the other
    International Stock News

    Why AstraZeneca's potential vaccine is more exciting than you think

    Investors are missing the big picture in the drugmaker's vaccine announcement.

    Read more »

    Cash piled up in the middle of a bear trap symbolising risky investments
    International Stock News

    Why Moderna Is Less Risky Than You Think

    Its coronavirus vaccine will likely be successful; its technology has huge potential; and the company has a healthy balance sheet.

    Read more »

    Profile

    since

    Note